Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM2Q3CL)

• Drug Name: Dimemorfan Drug Info
• Synonyms: Dimemorfan (INN); 36309-01-0; SCHEMBL509122

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 3037918
  ChEBI ID: CHEMBL135048
  CAS Number: CAS 36309-01-0
  TTD Drug ID: DM2Q3CL

Molecule-Related Drug Atlas

Drug(s) Targeting Opioid receptor sigma 1 (OPRS1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Dextromethorphan	DMUDJZM	Allergic rhinitis	CA08.0	Approved	[3]
Dextromethorphan Polistirex	DMEHCY5	Dry cough	MD12	Approved	[4]
CM-2395	DMASPWR	Schizophrenia	6A20	Phase 3	[5]
AVP-786	DMV1SOR	Alzheimer disease	8A20	Phase 3	[6]
ADX N05	DMLBYRA	Mood disorder	6A60-6E23	Phase 3	[7]
Igmesine	DMH97XA	Major depressive disorder	6A70.3	Phase 2	[8]
OPC-14523	DMB1WF3	Bulimia nervosa	6B81	Phase 2	[9]
ANAVEX 2-73	DM67OU4	Alzheimer disease	8A20	Phase 1	[10]
SSR-125047	DMSUFW6	Schizophrenia	6A20	Phase 1	[11]
SA-5845	DM6XZRL	Central nervous system disease	8A04-8D87	Phase 1	[12]

Drug(s) Affected By Cytochrome P450 2C19 (CYP2C19)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Cannabidiol	DM0659E	Dravet syndrome	8A61.11	Approved	[13]
Thioridazine	DM35M8J	Schizophrenia	6A20	Approved	[14]
Voriconazole	DMAOL2S	Aspergillosis	1F20	Approved	[15]
Chloramphenicol	DMFXEWT	Bacterial infection	1A00-1C4Z	Approved	[16]
Capsaicin	DMGMF6V	Back pain	ME84.Z	Approved	[17]
Pentamidine	DMHZJCG	African trypanosomiasis	1F51	Approved	[18]
Stiripentol	DMMSDOY	Dravet syndrome	8A61.11	Approved	[19]
Quinine	DMSWYF5	Malaria	1F40-1F45	Approved	[18]
Desipramine	DMT2FDC	Attention deficit hyperactivity disorder	6A05.Z	Approved	[14]
Amitriptyline	DMK7F9S	Depression	6A70-6A7Z	Approved	[20]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Opioid receptor sigma 1 (OPRS1)	TT5TPI6	SGMR1_HUMAN	Agonist	[1]

Drug Off-Target (DOT)

DOT Name	DOT ID	UniProt ID	Interaction	REF
Cytochrome P450 2C19 (CYP2C19)	OTFMJYYE	CP2CJ_HUMAN	Biotransformations	[2]

References

• [1] Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation. J Neurochem. 2008 Jan;104(2):558-72.
• [2] The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes. J Pharm Sci. 2010 Feb;99(2):1063-77.
• [3] Dextromethorphan/quinidine: AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan. Drugs R D. 2005;6(3):174-7.
• [4] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [5] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031127)
• [6] Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82.
• [7] Clinical pipeline report, company report or official report of SK BioPhamaceuticals.
• [8] Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J Pharmacol Exp Ther. 2006 Jun;317(3):1307-19.
• [9] Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. Neuropharmacology. 2001 Dec;41(8):976-88.
• [10] 2011 Pipeline of Anavex.
• [11] The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
• [12] Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study. J Nucl Med. 2004 Nov;45(11):1939-45.
• [13] Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
• [14] Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
• [15] The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
• [16] Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol Lett. 2016 Jan 22;241:82-94.
• [17] Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
• [18] Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
• [19] Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
• [20] ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.